{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:29:21Z","timestamp":1765546161463,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.dld.2017.01.154","type":"journal-article","created":{"date-parts":[[2017,1,22]],"date-time":"2017-01-22T08:45:33Z","timestamp":1485074733000},"page":"630-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Insulin promotes HER2 signaling activation during Barrett\u2019s Esophagus carcinogenesis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-6513","authenticated-orcid":false,"given":"Diletta","family":"Arcidiacono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Antonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Morbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Nitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Realdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.01.154_bib0005","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","article-title":"Esophageal adenocarcinoma incidence: are we reaching the peak?","volume":"19","author":"Pohl","year":"2010","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"10.1016\/j.dld.2017.01.154_bib0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s10620-013-3024-z","article-title":"Body mass index, smoking, and alcohol and risks of Barrett\u2019s esophagus and esophageal adenocarcinoma: a UK prospective cohort study","volume":"59","author":"Yates","year":"2014","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2017.01.154_bib0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/00365521.2013.873818","article-title":"Visceral adipose tissue: the link with esophageal adenocarcinoma","volume":"49","author":"Massl","year":"2014","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.154_bib0020","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1530\/ERC-11-0374","article-title":"Obesity, type 2 diabetes, and cancer: the insulin and IGF connection","volume":"19","author":"Cohen","year":"2012","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.dld.2017.01.154_bib0025","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/ijc.27887","article-title":"The risk of Barrett\u2019s esophagus associated with abdominal obesity in males and females","volume":"132","author":"Kendall","year":"2013","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.dld.2017.01.154_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MCG.0b013e3182a030c4","article-title":"The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis","volume":"48","author":"Jinjuvadia","year":"2014","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2017.01.154_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11892-010-0101-y","article-title":"Insulin, insulin resistance, obesity, and cancer","volume":"10","author":"Gallagher","year":"2010","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.dld.2017.01.154_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10911-013-9303-7","article-title":"Insulin and IGFs in obesity-related breast cancer","volume":"18","author":"Belardi","year":"2013","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"key":"10.1016\/j.dld.2017.01.154_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-32-14","article-title":"Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience","volume":"32","author":"Capasso","year":"2013","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"10.1016\/j.dld.2017.01.154_bib0050","article-title":"Association between diabetes and esophageal cancer, independent of obesity, in the united States Veterans Affairs population","author":"Dixon","year":"2015","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2017.01.154_bib0055","first-page":"e27488","article-title":"Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II","volume":"6","author":"Alvino","year":"2011","journal-title":"Public Library of Science"},{"key":"10.1016\/j.dld.2017.01.154_bib0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; regulation by AKT and 14-3-3 proteins","volume":"1813","author":"Tzivion","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.dld.2017.01.154_bib0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10911-008-9107-3","article-title":"Cross-talk between the ErbB\/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer","volume":"13","author":"Jin","year":"2008","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"key":"10.1016\/j.dld.2017.01.154_bib0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2017.01.154_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab\u2014mechanism of action and use in clinical practice","volume":"357","author":"Hudis","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2017.01.154_bib0080","first-page":"25","article-title":"HER2 status in Barrett\u2019s esophagus & esophageal cancer: a meta analysis","volume":"5","author":"Gowryshankar","year":"2014","journal-title":"Journal of Gastrointestinal Oncology"},{"key":"10.1016\/j.dld.2017.01.154_bib0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/dote.12210","article-title":"In vivo molecular imaging of HER2 expression in a rat model of Barrett\u2019s esophagus adenocarcinoma","volume":"28","author":"Realdon","year":"2015","journal-title":"Diseases of the Esophagus"},{"key":"10.1016\/j.dld.2017.01.154_bib0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/1078-0432.CCR-11-2272","article-title":"Association of HER2\/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas","volume":"18","author":"Yoon","year":"2012","journal-title":"Clinical Cancer Research"},{"year":"2010","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","key":"10.1016\/j.dld.2017.01.154_bib0095"},{"key":"10.1016\/j.dld.2017.01.154_bib0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"year":"2012","series-title":"Global Guideline for Type 2 Diabetes","key":"10.1016\/j.dld.2017.01.154_bib0105"},{"key":"10.1016\/j.dld.2017.01.154_bib0110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10552-008-9278-7","article-title":"Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability","volume":"20","author":"Swede","year":"2009","journal-title":"Cancer Causes and Control"},{"key":"10.1016\/j.dld.2017.01.154_bib0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2741\/E609","article-title":"C-peptide in diabetes diagnosis and therapy","volume":"5","author":"Ludvigsson","year":"2013","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.dld.2017.01.154_bib0120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jso.23923","article-title":"Absence or low IGF-1R-expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection","volume":"111","author":"De Bruijn","year":"2015","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2017.01.154_bib0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F","article-title":"Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer","volume":"89","author":"Schnarr","year":"2000","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.dld.2017.01.154_bib0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3892\/ol.2011.396","article-title":"IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: initial report","volume":"2","author":"Kuklinski","year":"2011","journal-title":"Oncology Letters"},{"key":"10.1016\/j.dld.2017.01.154_bib0135","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.humpath.2007.03.013","article-title":"The insulin-like growth factor type 1 receptor and colorectal neoplasia: insights into invasion","volume":"38","author":"Allison","year":"2007","journal-title":"Human Pathology"},{"key":"10.1016\/j.dld.2017.01.154_bib0140","doi-asserted-by":"crossref","first-page":"11118","DOI":"10.1158\/0008-5472.CAN-04-3841","article-title":"Insulin-like growth factor-I receptor\/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells","volume":"65","author":"Nahta","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.dld.2017.01.154_bib0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.dld.2017.01.154_bib0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/ERC-12-0333","article-title":"Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer","volume":"20","author":"Ferguson","year":"2013","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.dld.2017.01.154_bib0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2011-300641","article-title":"Association of insulin and insulin-like growth factors with Barrett\u2019s oesophagus","volume":"61","author":"Greer","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.01.154_bib0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2013.04.010","article-title":"The PRB-dependent FOXO1\/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth","volume":"336","author":"Nakamura","year":"2013","journal-title":"Cancer Letters"},{"issue":"Suppl. A","key":"10.1016\/j.dld.2017.01.154_bib0165","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1096-6374(00)90004-2","article-title":"Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3","volume":"10","author":"Baxter","year":"2000","journal-title":"Growth Hormone and IGF Research"},{"key":"10.1016\/j.dld.2017.01.154_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2045-3701-4-59","article-title":"Posttranslational regulation of Akt in human cancer","volume":"4","author":"Chan","year":"2014","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.dld.2017.01.154_bib0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2014.00357","article-title":"Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin\/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells","volume":"5","author":"Rozengurt","year":"2014","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.dld.2017.01.154_bib0180","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/cr.2014.99","article-title":"The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes","volume":"24","author":"Wang","year":"2014","journal-title":"Cell Research"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817301585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817301585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T17:20:26Z","timestamp":1568740826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817301585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1590865817301585"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.01.154","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin promotes HER2 signaling activation during Barrett\u2019s Esophagus carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.01.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}